HEIDELBERG-ENGINEERING
Heidelberg Engineering, the leader in diagnostic imaging known for the internationally-acclaimed SPECTRALIS ® retina and glaucoma platform, announces the CE-marking of ANTERION ® – an innovative platform designed to transform anterior segment diagnostics and workflow.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005442/en/
The new ANTERION provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. It is a single, workflow-efficient solution that brings together corneal topography and tomography, anterior segment metrics, axial length measurement and IOL calculation to transform the day-to-day routine of busy practices and clinics.
Heidelberg Engineering has leveraged its core OCT technologies in the development of the ANTERION, making the best use not only of swept-source OCT but also of patented tracking and composite imaging technologies to deliver exceptionally high-quality images of the anterior segment. Visual confirmation of all measurements with high-resolution swept-source OCT images establishes a new level of diagnostic confidence.
Prof. Oliver Findl, from the Hanusch Hospital in Vienna confirms the exceptional quality of the ANTERION images: “We had high-contrast and high-resolution OCT images of the entire anterior segment with little or no artifact movements. The scans were possible in eyes with different pathologies of the anterior and posterior segment.”
“ANTERION is a multimodal imaging platform, which can replace several devices, including corneal topographers and tomographers, pachymeters and biometers,” said Jacqueline Sousa Asam, MD, Medical Science Liaison at Heidelberg Engineering. “That leads to great improvement in the workflow and patient comfort in busy clinics, since moving patients can be unpleasant and time consuming. In addition, ANTERION displays information in very comprehensive layouts together with high-resolution OCT images, which also makes surgical planning faster and more efficient.”
Modular design: Imaging, Cornea, Cataract, and Metrics Apps
As the foundation of the ANTERION platform, the Imaging App focuses on the high-resolution visualization of the entire anterior segment, from the anterior surface of the cornea to the posterior surface of the lens. The other ANTERION Apps adjust to various clinical needs.
The Cornea App provides a comprehensive diagnostic solution to assess a patient’s individual corneal geometry. Corneal alterations can be diagnosed and monitored and the planning and evaluation of refractive surgery enhanced.
The Cataract App combines key measurements for cataract surgery planning: corneal analysis, anterior chamber depth, lens thickness, and axial length. The ability to assess total corneal power supports a more suitable IOL selection, while the integrated spheric and toric IOL calculator adds convenience to the pre-operative routine.
The Metrics App features swept-source OCT images with the anterior chamber displayed in a radial view. Predefined angle parameters can be determined and free-hand measurements can also be performed.
Swept-source and spectral domain OCT optimized at Heidelberg Engineering
Heidelberg Engineering has optimized swept-source OCT technology for anterior segment imaging on the new ANTERION and will continue to innovate with spectral domain OCT retinal imaging on the SPECTRALIS. Both imaging platforms aim to deliver the highest-quality images that empower eye care professionals to make confident diagnostic decisions that ultimately improve patient care.
Click on image or caption to download high resolution file
About ANTERION: www.anterion.com
About Heidelberg Engineering: www.heidelbergengineering.com/int/company
View source version on businesswire.com: https://www.businesswire.com/news/home/20180921005442/en/
Contact:
Heidelberg Engineering Media contact Leticia Jimenez Leticia.Jimenez@HeidelbergEngineering.com +49 (0)6221 64 63 317
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rimini Street Announces Upcoming 2025 Investor Conference Schedule15.5.2025 22:51:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that Michael L. Perica, chief financial officer, and Dean Pohl, vice president, treasurer and investor relations, will be presenting and meeting with investors one-on-one and in small group meetings at the following conferences: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515374696/en/ Rimini Street Announces Upcoming 2025 Investor Conference Schedule May 28, 2025: Craig-Hallum 22nd Annual Institutional Investor Conference, Minneapolis May 29, 2025: TD Cowen 53rd Annual TMT Conference, New York City Fireside Chat: 1:15 pm Eastern, webcast link June 24-26, 2025: Roth 15th Annual London Conference, London To schedule a meeting please contact your salesperson or Rimini Street Investor Relations at IR@rimin
Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States15.5.2025 20:30:00 CEST | Press release
Zynyz® (retifanlimab-dlwr), a PD-1 inhibitor, is now approved for the treatment of advanced squamous cell carcinoma of the anal canal (SCAC) in combination with chemotherapy and as a monotherapyPatients with SCAC treated with Zynyz achieved a statistically significant improvement in progression-free survival and improvement in overall survival Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz® (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC). In addition, the FDA granted approval for Zynyz as a single agent for the treatment of adult patients with locally recurrent or with metastatic SCAC with disease progression on or intolerance to platinum-based chemotherapy. Thi
DDC Announces Record 2024 Growth and Strategic Bitcoin Reserve Initiative in Shareholder Letter by Founder & CEO Norma Chu15.5.2025 20:23:00 CEST | Press release
DDC Enterprise Ltd. (NYSEAM: DDC), today released its 2024 full year results alongside a Shareholder Letter from Founder, Chairwoman, and CEO Norma Chu, underscoring the company’s positive financial performance and unveiling a pioneering Bitcoin accumulation strategy poised to redefine long-term value creation. To Our Valued Shareholders, 2024 was a year of transformative growth and strategic milestones for DDC. I am thrilled to share that we not only met our financial forecasts but exceeded expectations, delivering strong performance across key metrics while laying the groundwork for an even more exciting future. As we enter 2025, our momentum is accelerating, driven by disciplined execution and a bold new chapter in our corporate strategy. 2024 Financial & Operational HighlightsRevenue Growth: USD 37.4 million, a 33% year-over-year increase, propelled by the strategic acquisition of U.S. brands and sustained resilience in our core China operations. Margin Expansion: Gross profit marg
Ras Al Khaimah’s Strong Economic and Investment Environment Validated by Fitch Affirmation of ‘A+’ Credit Rating, With Stable Outlook15.5.2025 20:18:00 CEST | Press release
The positive rating reflects the Emirate’s strong long-term growth prospects and ongoing economic diversification Ras Al Khaimah’s strategic approach to sustainable, cross-sector growth and strong economic and investment environment has been validated by international credit rating agency Fitch, which reaffirmed the rating at ‘A+’ with a stable outlook. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515907689/en/ Ras Al Khaimah’s strong economic and investment environment validated by Fitch affirmation of ‘A+’ credit rating, with Stable Outlook (Photo: AETOSWire) Ras Al Khaimah Government welcomed the announcement as an endorsement of the Emirate’s resilient and expanding economy, sound fiscal management and the clear vision and unwavering commitment of its leadership to sustainable, long-term development and growth. The Emirate’s landmark tourism projects, including a major integrated resort, luxury hotels and world-clas
Cessna Citation CJ4 Gen3 Flight Test Program Advances Through Milestones as Second Test Article Takes Flight15.5.2025 20:00:00 CEST | Press release
Textron Aviation today announced a major program milestone for the Cessna Citation CJ4 Gen3 flight test program with the successful first flight of a second test article — P1. Testing on the P1 aircraft will focus on avionics, human factors and interiors. The Citation CJ4 Gen3 business jet is designed to keep pilots a step ahead in the cockpit by offering the next-generation Garmin G3000 PRIME avionics along with the most standard features in its class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515438856/en/ Cessna Citation CJ4 Gen3 flight test program advances through milestones as second test article takes flight. (Photo Credit: Textron Aviation) The Cessna Citation CJ4 Gen3 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. “This achievement continues the forward momentum of the CJ4 Gen3 program and reflects the dedication and expertise of our team in designing, certifying an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom